Salvage radiotherapy after high-intensity focussed ultrasound for recurrent localised prostate cancer

European Urology

Volumn 58, Issue 4, 2010, Pages 567-573

  Riviere, Julien ^a   Bernhard, Jean Christophe ^a   Robert, Grégoire ^a   Wallerand, Hervé ^a   Deti, Edouard ^b   Maurice Tison, Sylvie ^b   Ardiet, Jean Michel ^c   Maire, Jean Philippe ^a   Richaud, Pierre ^d   Ferriere, Jean Marie ^a   Ballanger, Philippe ^a   Gelet, Albert ^e   Pasticier, Gilles ^a  

^a HÔPITAL PELLEGRIN   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Clinique Saint Jean   (France)

^d INSTITUT BERGONIÉ   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

HIFU; Local recurrence; Minimally invasive surgery; Oncologic control; Prognostic factors; Prostate cancer; Salvage radiotherapy; Tolerance; Toxicity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADOLESCENT; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED RADIOTHERAPY; ERECTILE DYSFUNCTION; GASTROINTESTINAL TOXICITY; HIGH INTENSITY FOCUSED ULTRASOUND; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; RADIATION DOSE; RADIATION HAZARD; RADIATION RESPONSE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT FAILURE; UNIVARIATE ANALYSIS; URINE INCONTINENCE;

EID: 78650710562     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.06.003     Document Type: Article

References (30)

1. A. Blana, F.J. Murat, and B. Walter First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer Eur Urol 53 2008 1194 1203
2. L. Poissonnier, J.Y. Chapelon, and O. Rouvire Control of prostate cancer by transrectal HIFU in 227 patients Eur Urol 51 2007 381 387
3. C. Catton Post-Operative radiotherapy following radical prostatectomy Eur Urol Update 3 2 2005 107 116
4. D. Pasquier, and C. Ballereau Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review Int J Radiat Oncol Biol Phys 72 2008 972 979
5. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
6. J.P. Brooks, P.S. Albert, and R.B. Wilder Long-term salvage radiotherapy outcome after radical prostatectomy and relapse predictors J Urol 174 2005 2204 2208
7. G. Pasticier, O. Chapet, and L. Badet Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical results Urology 72 2008 1305 1309
8. M. Soulié, P. Beuzeboc, and F. Cornud Prostatic cancers [in French] Prog Urol 17 2007 1159 1230
9. L. Poissonnier, F.-J. Murat, J.-Y. Chapelon, and A. Gelet Indications, techniques et résultats du traitement par ultrasons focalisés (HIFU) du cancer localisé de la prostate Ann Urol 41 2007 237 253
10. A.V. D'Amico, J. Moul, P.R. Carroll, L. Sun, D. Lubeck, and M.H. Chen Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era J Clin Oncol 21 2003 2163 2172
11. A. Trotti The evolution and application of toxicity criteria Semin Radiat Oncol 12 Suppl 1 2002 1 3
12. A. Ingelman-Sundberg, and U. Ulmsten Surgical treatment of female urinary stress incontinence Contrib Gynecol Obstet 10 1983 51 69
13. R.C. Rosen, A. Riley, and G. Wagner The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction Urology 49 1997 822 830
14. A. Blana, B. Walter, S. Rogenhofer, and W.F. Wieland High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience Urology 63 2004 297 300
15. J.U. Stolzenburg, B. Bynens, and M. Do Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer Urology 70 2007 956 960
16. E. Liatsikos, B. Bynens, and R. Rabenalt Treatment of patients after failed high intensity focused ultrasound and radiotherapy for localized prostate cancer: salvage laparoscopic extraperitoneal radical prostatectomy J Endourol 22 2008 2295 2298
17. H.I. Scher, M. Eisenberger, and A.V. D'Amico Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group J Clin Oncol 22 2004 537 556
18. M. Roach, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974
19. M. Bolla, L. Collette, and L. Blank Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial Lancet 360 2002 103 106
20. A.L. Hanlon, H. Diratzouian, and G.E. Hanks Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer Int J Radiat Oncol Biol Phys 53 2002 297 303
21. F.J. Murat, L. Poissonnier, and M. Rabilloud Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer Eur Urol 55 2009 640 649
22. A. Gelet, J.Y. Chapelon, and L. Poissonnier Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography Urology 63 2004 625 629
23. W.U. Shipley, H.D. Thames, and H.M. Sandler Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis JAMA 281 1999 1598 1604
24. F.A. Critz Time to achieve a prostate-specific antigen nadir of 0.2 ng./ml. after simultaneous irradiation for prostate cancer J Urol 168 2002 2434 2438
25. R. Ganzer, S. Rogenhofer, and B. Walter PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer Eur Urol 53 2008 547 553
26. O. Rouvire, N. Girouin, and L. Glas Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI Eur Radiol 20 2010 48 55
27. P.A. Kupelian, T.R. Willoughby, and C.A. Reddy Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience Int J Radiat Oncol Biol Phys 68 2007 1424 1430
28. M.J. Zelefsky, E.J. Levin, and M. Hunt Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer Int J Radiat Oncol Biol Phys 70 2008 1124 1129
29. T.E. Schultheiss, W.R. Lee, and M.A. Hunt Late GI and GU complications in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 37 1997 3 11
30. C.A. Lawton, M. Won, and M.V. Pilepich Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706 Int J Radiat Oncol Biol Phys 21 1991 935 939